• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers

Get started
Sign in
Close
Evaluating changes in lidocaine and opioid administration on the day of IUD insertion, 2018-2025

Evaluating changes in lidocaine and opioid administration on the day of IUD insertion, 2018-2025

by Truveta Research | Feb 2, 2026 | Featured research, Research

Authors: Nina B. Masters, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Karen G. Farrar, PhD ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Duy Do, PhD ⊕Truveta, Inc,...
Truveta experts: What adolescent sleep disorders reveal about mental health trends

Truveta experts: What adolescent sleep disorders reveal about mental health trends

by Truveta staff | Feb 2, 2026 | Research

In this Truveta experts analysis, Karen Gilbert Farrar, PhD examines the relationship between sleep disorders and mental health conditions among adolescents using Truveta’s de-identified electronic health record (EHR) data. The analysis focuses on patients ages 12–17...
Real-world survival outcomes after cardiac contractility modulation: New research from Impulse Dynamics

Real-world survival outcomes after cardiac contractility modulation: New research from Impulse Dynamics

by Truveta staff | Jan 29, 2026 | Research

New peer-reviewed research published in the Journal of Cardiac Failure offers promising real-world evidence on long-term survival after cardiac contractility modulation (CCM), a device-based therapy for patients with symptomatic heart failure who are not candidates...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends through December 2025 

Real-time monitoring of respiratory virus-associated hospitalizations: Trends through December 2025 

by Truveta Research | Jan 23, 2026 | Featured research, Research

Respiratory virus–associated hospitalizations increased substantially (+125.3%) in December 2025 and accounted for nearly 7% of all hospitalizations by the last week of the month. This increase was driven primarily by a rise in influenza-associated hospitalizations...
Rising use of robotic-assisted surgery in hysterectomy, cholecystectomy, and inguinal hernia repair

Rising use of robotic-assisted surgery in hysterectomy, cholecystectomy, and inguinal hernia repair

by Truveta Research | Jan 21, 2026 | Research

From 2018 to 2025, robotic-assisted surgery increased across hysterectomy, cholecystectomy, and inguinal hernia repair, with robotic use in cholecystectomy increasing more than six-fold over the study period. Across all procedures, patients with higher comorbidity...
GLP-1 RA prescription trends: January 2019 – December 2025

GLP-1 RA prescription trends: January 2019 – December 2025

by Truveta Research | Jan 20, 2026 | Research

As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions. Tirzepatide continues to be the most prescribed anti-diabetic (ADM) and anti-obesity (AOM) medication (sold as Mounjaro and Zepbound, respectively) and showed the largest...
« Older Entries
Next Entries »

Share this


Recent posts

  • CDC publishes national COVID-19 analysis using Truveta Data
  • The FDA just changed the rules. Here’s what we owe patients.
  • With the FDA ending the two-trial default, the era of intelligent evidence has begun

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

News

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.